Showing 2821-2830 of 20410 results for "".
Biologics for Inflammatory Bowel Disease: Maximizing Benefits, Avoiding Complications
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/biologics-for-inflammatory-bowel-disease-maximizing-benefits-avoiding-complications/8476/Drs. Lea Ann Chen and Gary Lichtenstein discuss potential complications of biologics for patients with IBD.Improving Adherence Among HF Patients: A Look at the PROMPT-HF Trial
https://reachmd.com/programs/heart-matters/improving-adherence-among-hf-patients-a-look-at-the-prompt-hf-trial/13733/Can targeted electronic health record alerts recommending guideline-directed medical therapy help improve adherence among heart failure patients?The IgG Clock: Redose Using IgG Kinetics
https://reachmd.com/programs/cme/the-igg-clock-redose-using-igg-kinetics/54772/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Applying Perioperative ICIs in Clinical Practice
https://reachmd.com/programs/cme/applying-perioperative-icis-in-clinical-practice/36634/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.Managing Immune-Related Adverse Events in the Perioperative Setting
https://reachmd.com/programs/cme/managing-immune-related-adverse-events-in-the-perioperative-setting/36635/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.Emerging Evidence for Perioperative ICIs in Locally Advanced HNSCC
https://reachmd.com/programs/cme/emerging-evidence-for-perioperative-icis-in-locally-advanced-hnscc/36593/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.Investigator Interview: Volume Progression in ADPKD
https://reachmd.com/cme/nephrology/investigator-interview-volume-progression-in-adpkd/12849/Investigator Interview: Volume Progression in ADPKDHow Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021
https://reachmd.com/programs/project-oncology/how-social-determinants-impact-cancer-outcomes-insights-from-asco-2021/12649/Coming to you from the floors of the 2021 ASCO Annual Meeting, here’s a look at how social determinants—not biology—impact our patients’ outcomes.Gut-Selective Therapy: Understanding Anti-Integrins in IBD
https://reachmd.com/programs/cme/gut-selective-therapy-understanding-anti-integrins-in-ibd/60778/Explore IBD treatment selection in this comprehensive program for community gastroenterologists, with topics including therapies, targets, and emerging data.The Future of Biologic Treatment in IBD: What’s on the Horizon
https://reachmd.com/programs/cme/the-future-of-biologic-treatment-in-ibd-whats-on-the-horizon/60780/Explore IBD treatment selection in this comprehensive program for community gastroenterologists, with topics including therapies, targets, and emerging data.